Search

Your search keyword '"Attal M."' showing total 879 results

Search Constraints

Start Over You searched for: Author "Attal M." Remove constraint Author: "Attal M."
879 results on '"Attal M."'

Search Results

1. Catchment‐Averaged Erosion Rates Reveal Signals of Divide Migration and Drainage Capture.

5. Second primary malignancies in multiple myeloma: an overview and IMWG consensus

6. Kaposi's Sarcoma-Associated Herpesvirus Infection and Multiple Myeloma

8. Safe and prolonged survival with long-term exposure to pomalidomide in relapsed/refractory myeloma

9. Variation saisonnière du régime alimentaire de la carpe (Cyprinus carpio) au niveau du lac barrage Ghrib (Ain Defla) Algérie

10. Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients

13. A 4-weekly course of rituximab is safe and improves tumor control for patients with minimal residual disease persisting 3 months after autologous hematopoietic stem-cell transplantation: results of a prospective multicenter phase II study in patients with follicular lymphoma

15. Early Allogeneic Transplantation Favorably Influences the Outcome of Adult Patients Suffering from Acute Myeloid Leukemia

16. HESEB: The Helmholtz state-of-the-art Soft-X-Ray Undulator beamline at SESAME

17. IL2 in Acute Leukemia

22. Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients

23. Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European group for Blood and Marrow Transplantation

24. Prospective Study Comparing Idarubicin and Daunorubicin in Elderly Patients with Acute Myeloid Leukemia

28. Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study

29. The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT

37. International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)

38. International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation

40. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

41. Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial

42. Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma

43. Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trials

45. A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial

46. International uniform response criteria for multiple myeloma

49. Consolidation with VTd significantly improves the complete remission rate and time to progression following VTd induction and single autologous stem cell transplantation in multiple myeloma

Catalog

Books, media, physical & digital resources